OTR Global downgrades Weibo (NASDAQ:WB) from Mixed to Negative.
Corcept Initiates MONARCH A Phase 2b Trial Of Its Proprietary Selective Cortisol Modulator Miricorilant In Patients With Non-Alcoholic Steatohepatitis
Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism, and neurology disorders by modulating